Yonghe Medical Group Co., Ltd.

SEHK:2279 Stock Report

Market Cap: HK$500.2m

Yonghe Medical Group Future Growth

Future criteria checks 3/6

Yonghe Medical Group is forecast to grow earnings and revenue by 136.7% and 6.1% per annum respectively. EPS is expected to grow by 137.3% per annum. Return on equity is forecast to be 12.7% in 3 years.

Key information

136.7%

Earnings growth rate

137.3%

EPS growth rate

Healthcare earnings growth14.5%
Revenue growth rate6.1%
Future return on equity12.7%
Analyst coverage

Low

Last updated03 Apr 2025

Recent future growth updates

Recent updates

Yonghe Medical Group Co., Ltd. (HKG:2279) Stock Catapults 31% Though Its Price And Business Still Lag The Industry

Mar 07
Yonghe Medical Group Co., Ltd. (HKG:2279) Stock Catapults 31% Though Its Price And Business Still Lag The Industry

Yonghe Medical Group Co., Ltd.'s (HKG:2279) Shares Bounce 36% But Its Business Still Trails The Industry

Dec 12
Yonghe Medical Group Co., Ltd.'s (HKG:2279) Shares Bounce 36% But Its Business Still Trails The Industry

Yonghe Medical Group Co., Ltd.'s (HKG:2279) Shares Leap 60% Yet They're Still Not Telling The Full Story

Sep 30
Yonghe Medical Group Co., Ltd.'s (HKG:2279) Shares Leap 60% Yet They're Still Not Telling The Full Story

Is Yonghe Medical Group (HKG:2279) Using Debt Sensibly?

May 24
Is Yonghe Medical Group (HKG:2279) Using Debt Sensibly?

It's Down 34% But Yonghe Medical Group Co., Ltd. (HKG:2279) Could Be Riskier Than It Looks

Mar 31
It's Down 34% But Yonghe Medical Group Co., Ltd. (HKG:2279) Could Be Riskier Than It Looks

Are Yonghe Medical Group Co., Ltd. (HKG:2279) Investors Paying Above The Intrinsic Value?

Oct 19
Are Yonghe Medical Group Co., Ltd. (HKG:2279) Investors Paying Above The Intrinsic Value?

The Consensus EPS Estimates For Yonghe Medical Group Co., Ltd. (HKG:2279) Just Fell Dramatically

Sep 08
The Consensus EPS Estimates For Yonghe Medical Group Co., Ltd. (HKG:2279) Just Fell Dramatically

Is Yonghe Medical Group Co., Ltd. (HKG:2279) Expensive For A Reason? A Look At Its Intrinsic Value

Aug 19
Is Yonghe Medical Group Co., Ltd. (HKG:2279) Expensive For A Reason? A Look At Its Intrinsic Value

Yonghe Medical Group's (HKG:2279) Soft Earnings Don't Show The Whole Picture

Mar 31
Yonghe Medical Group's (HKG:2279) Soft Earnings Don't Show The Whole Picture

Earnings and Revenue Growth Forecasts

SEHK:2279 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,036100N/A1881
12/31/20251,84932N/A921
12/31/20241,804-226175229N/A
9/30/20241,827-34087155N/A
6/30/20241,850-453082N/A
3/31/20241,813-496-9432N/A
12/31/20231,777-538-188-17N/A
9/30/20231,635-430-246-35N/A
6/30/20231,492-322-304-54N/A
3/31/20231,453-203-328-81N/A
12/31/20221,413-84-352-109N/A
9/30/20221,6386-20615N/A
6/30/20221,86395-59139N/A
3/31/20222,01610794288N/A
12/31/20212,169118247437N/A
9/30/20212,129121301492N/A
6/30/20212,090125355546N/A
3/31/20211,864136357524N/A
12/31/20201,638147359502N/A
12/31/20191,2243674182N/A
12/31/20189345458195N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 2279 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.4%).

Earnings vs Market: 2279 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 2279 is expected to become profitable in the next 3 years.

Revenue vs Market: 2279's revenue (6.1% per year) is forecast to grow slower than the Hong Kong market (8.1% per year).

High Growth Revenue: 2279's revenue (6.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 2279's Return on Equity is forecast to be low in 3 years time (12.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/25 06:49
End of Day Share Price 2025/04/25 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Yonghe Medical Group Co., Ltd. is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yichi ZhangChina International Capital Corporation Limited
Liting WangHaitong International Research Limited
Wenzheng LiuMinsheng Securities Co.